Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections. Antimicrob Agents Chemother 2004 Mar;48(3):1012-6

Date

02/26/2004

Pubmed ID

14982797

Pubmed Central ID

PMC353113

DOI

10.1128/aac.48.3.1012-1016.2004

Scopus ID

2-s2.0-1442275602   76 Citations

Abstract

The in vitro activities of moxifloxacin, ciprofloxacin, levofloxacin, gatifloxacin, imipenem, piperacillin-tazobactam, clindamycin, and metronidazole against 900 surgical isolates were determined using NCCLS testing methods. Moxifloxacin exhibited good to excellent antimicrobial activity against most aerobic (90.8%) and anaerobic (97.1%) microorganisms, suggesting that it may be effective for the treatment of polymicrobial surgical infections.

Author List

Edmiston CE, Krepel CJ, Seabrook GR, Somberg LR, Nakeeb A, Cambria RA, Towne JB

Author

Gary R. Seabrook MD Chief, Professor in the Surgery department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Abdomen
Anti-Infective Agents
Aza Compounds
Bacteria, Aerobic
Bacteria, Anaerobic
Bacterial Infections
Diabetic Foot
Fluoroquinolones
Humans
Microbial Sensitivity Tests
Quinolines
jenkins-FCD Prod-398 336d56a365602aa89dcc112f077233607d6a5abc